Crossmark

Nanoparticle formulated vaccines: opportunities and challenges

Published Online: 2020

Authors

Lung, Pingsai https://orcid.org/0000-0002-5233-2846
Yang, Jingnan https://orcid.org/0000-0002-9738-5271
Li, Quan https://orcid.org/0000-0001-8563-1802
Funding

Funding for this research was provided by:

Health and Medical Research Fund (18170262)
License Information

Accepted Manuscript valid from 2021-02-18
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

IDENTIFIERS

: Pingsai Lung (ORCID)

: Jingnan Yang (ORCID)

: Quan Li (ORCID)

: Quan Li (ResearcherID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 19 October 2019; Accepted 31 January 2020; Accepted Manuscript published 18 February 2020; Advance Article published 3 March 2020; Version of Record published 12 March 2020

Document is current